Our first study on the involvement of LOX-1 in CRC has evidenced that LOX-1 resulted to be strongly increased in the 72% of human colon carcinomas, and strongly overexpressed in 90% of highly aggressive and metastatic tumors, if compared to healthy counterpart of the same patients [30]. The gene discussed is OLR1; the disease is colorectal carcinoma.